IRD EPS Estimates
Opus Genetics, Inc.
$4.19
+$0.09(+2.20%)
45
Overall
40
Value
45
Tech
50
Quality
Market Cap
$341.10M
Volume
45.89K
52W Range
$1.70 - $7.07
Target Price
$12.17
IRD EPS estimates: the consensus estimate for Opus Genetics, Inc.'s current fiscal year is -$0.97 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
IRD EPS Estimates
- EPS estimate, current quarter
- $-0.14
- EPS estimate, next quarter
- $-0.07
- EPS estimate, current year
- $-0.97
- EPS estimate, next year
- $-0.70
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.80 |
| 2024 | $-2.15 |
| 2023 | $-0.46 |
| 2022 | $0.90 |
| 2021 | $-3.82 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IRD | $4.19 | +2.2% | 45.89K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |